Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/5/2026

1. AMD
2. SPCX
3. BKNG
4. ANET
5. PINS
6. TOST
7. HNGE
8. QLYS
9. PRCT
10. W

Go back to Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study
(NASDAQ: LEXX) Delayed: 5.34 -0.28 (4.98%)
Previous Close $5.62    52 Week High $ 
Open $5.68    52 Week Low $ 
Day High $6.09    P/E N/A 
Day Low $5.23    EPS $ 
Volume 64,472